NCT00544791View on ClinicalTrials.gov

The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2007

Study Completion Date

October 31, 2010

Conditions
Mild Cognitive Impairment (MCI)
Interventions
DRUG

melatonin

5 mg, oral, daily dose for 6 months

DRUG

placebo like melatonin tablets

Trial Locations (1)

70300

RECRUITING

Memory clinic, 'Asaf Harofeh' medical center, Ẕerifin

Sponsors
All Listed Sponsors
collaborator

Neurim Pharmaceuticals Ltd.

INDUSTRY

lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT00544791 - The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter